Polaryx Therapeutics (PLYX) EPS (Basic) Growth (1y) (2026)
Powered by 
Analysis
Polaryx Therapeutics (PLYX) EPS (Basic) Growth (1y) (2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.58 Bn | 192.59 Bn | 7.24 Bn | 65.24% |
| 2 | Gilead Sciences | 180.17 Bn | 176.99 Bn | 6.22 Bn | -636.10% |
| 3 | Vertex Pharmaceuticals | 130.59 Bn | 122.74 Bn | 2.84 Bn | 7.74% |
| 4 | Regeneron Pharmaceuticals | 81.61 Bn | 73.61 Bn | 3.93 Bn | -4.72% |
| 5 | Argenx Se | 60.24 Bn | 55.05 Bn | 1.37 Bn | 87.85% |
| 6 | Moderna | 54.29 Bn | 49.15 Bn | 52.00 Mn | 7.59% |
| 7 | Alnylam Pharmaceuticals | 32.96 Bn | 29.65 Bn | 992.69 Mn | 322.67% |
| 8 | Biogen | 31.94 Bn | 30.66 Bn | 1.96 Bn | -84.77% |
| 9 | Roivant Sciences | 29.38 Bn | 29.38 Bn | 1.16 Mn | - |
| 10 | Polaryx Therapeutics | 97.52 Mn | 85.98 Mn | - | -26.67% |